The American Journal of Medicine
Volume 123, Issue 2 , Pages 173-181 , February 2010

Antihypertensive Drug Persistence and Compliance Among Newly Treated Elderly Hypertensives in Ontario

  • Oded Friedman, MD

      Affiliations

    • Prosserman Centre for Health Research (Samuel Lunenfeld Research Institute, Mount Sinai Hospital), Toronto, Canada
    • Institute For Clinical Evaluative Sciences, Toronto, Canada
    • Corresponding Author InformationReprint requests should be addressed to Oded Friedman, MD, c/o Prosserman Centre for Health Research (Samuel Lunenfeld Research Institute, Mount Sinai Hospital), 60 Murray Street, Toronto, Ontario, M5G1X5 Canada
    • ,
  • Finlay A. McAlister, MD

      Affiliations

    • Division of General Internal Medicine, University of Alberta, Edmonton, Canada
    • ,
  • Lingsong Yun, MD

      Affiliations

    • Institute For Clinical Evaluative Sciences, Toronto, Canada
    • ,
  • Norman R.C. Campbell, MD

      Affiliations

    • Departments of Medicine and Pharmacology and Therapeutics, Libin Cardiovascular Institute, University of Calgary, Canada
    • ,
  • Karen Tu, MD

      Affiliations

    • Institute For Clinical Evaluative Sciences, Toronto, Canada
    • University Health Network-Toronto Western Hospital Family Medicine Centre, Toronto, Canada
    • Department of Family and Community Medicine, University of Toronto, Canada
    • ,
  • Canadian Hypertension Education Program Outcomes Research Taskforce

  • Image Result

    Class persistence (%) by antihypertensive drug class. ACEI=angiotensin-converting inhibitor; ARB=angiotensin II receptor blocker; BB=beta-blocker; CCB=calcium channel blocker; DM=diabetic; Non-DM=nond

    Class persistence (%) by antihypertensive drug class. ACEI=angiotensin-converting inhibitor; ARB=angiotensin II receptor blocker; BB=beta-blocker; CCB=calcium channel blocker; DM=diabetic; Non-DM=nondiabetic.

  • Image Result
    Medication possession ratio greater than 0.8 (%) by antihypertensive drug class. ACEI=angiotensin-converting inhibitor; ARB=angiotensin II receptor blocker; BB=beta-blocker; CCB=calcium channel blocke

    Medication possession ratio greater than 0.8 (%) by antihypertensive drug class. ACEI=angiotensin-converting inhibitor; ARB=angiotensin II receptor blocker; BB=beta-blocker; CCB=calcium channel blocker; DM=diabetic; Non-DM = nondiabetic.

 Funding: Alberta Heritage Foundation for Medical Research.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(09)00797-9

doi: 10.1016/j.amjmed.2009.08.008

The American Journal of Medicine
Volume 123, Issue 2 , Pages 173-181 , February 2010

Article Tools

* Image Usage & Resolution